Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVOLUTION: Immediate Versus Extended Release Tacrolimus in Lung Transplantation
NCT05001074Phase 3Unknown
- Start
- Jul 2020
- Primary completion
- Aug 2024
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in lung transplant complications, calcineurin inhibitor toxicity. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
lung transplant complicationscalcineurin inhibitor toxicity
Beyond the preview
Go deeper on NCT05001074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001074.